ArticleComputational and structural biotechnology journal2025
ASVBM: Structural variant benchmarking with local joint analysis for multiple callsets.
Article in Computational and structural biotechnology journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Structural Variants in the Human Genome Associated With Gut Microbiome and Blood Metabolic Traits With Potential Causal Links.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Accurate benchmarking of structural variant (SV) detection is essential for advancing the development and application of human whole-genome sequencing (WGS). A fundamental challenge in benchmarking SV detection results is determining whether two SVs represent the same event. Differences in the variation-awareness and strategic implementation of aligners inherently constrain SV detection algorithms that rely on alignment-based approaches. Traditional benchmarking, which primarily focuses on comparing and matching individual variants, makes it difficult to capture the relationships between multiple adjacent variants. We introduced ASVBM, an improved benchmarking framework that introduces the notion of latent positives and leverages a joint analysis and validation strategy based on local variants. This performance improvement arose from the discovery that multiple smaller variants are nearly equivalent to a larger variant. We comprehensively evaluated the performance of six state-of-the-art variant calling pipelines using real WGS datasets. According to multiple matching criteria, ASVBM employs a joint analysis strategy to uncover potential equivalences between the callset and the benchmark set, thereby reducing false mismatches caused by differences in variant representation. ASVBM is available at https://github.com/zhuxiao/asvbm.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.